May 15 (Reuters)-
Kohjin Bio Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 4.94 5.21 4.72
(-5.1 pct) (+9.1 pct) (-4.4 pct)
Operating 341 mln 991 mln 137 mln
(-65.5 pct) (+66.1 pct) (-59.8 pct)
Recurring 340 mln 1.07 147 mln
(-68.0 pct) (+67.6 pct) (-56.8 pct)
Net
Net 251 mln 794 mln 110 mln
(-68.4 pct) (+106.4 pct) (-55.9 pct)
EPS 49.11 yen 157.57 yen 21.65 yen
Ann Div 10.00 yen 24.00 yen 10.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 10.00 yen 24.00 yen 10.00 yen
NOTE - Kohjin Bio Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=177A.T